GEOFFREY NICHOL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GEOFFREY NICHOL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEOFFREY NICHOL. GEOFFREY NICHOL is a Senior Vice President in MEDAREX INC ($MEDX) and a Sr. V. P. Product Development in MEDAREX INC ($MEDX) and an Executive Vice President, R&D in SANGAMO BIOSCIENCES INC ($SGMO) and a Director in Millendo Therapeutics, Inc. ($OVAS).
Address: MEDAREX, INC. 707 STATE ROAD PRINCETON 08540 NJ
Companies in which GEOFFREY NICHOL is an Insider
MEDAREX INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of GEOFFREY NICHOL: Sr. V. P. Product Development, Senior Vice President
Holdings: 0 shares
Latest Transaction: Sep 03 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Millendo Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GEOFFREY NICHOL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 23 2020
$OVAS Market Capitalization: $55.19M
$OVAS Previous Close: $1.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SANGAMO THERAPEUTICS, INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GEOFFREY NICHOL: Executive Vice President, R&D
Holdings: 159,676 shares
Current Value: $614,753
Latest Transaction: Dec 15 2015
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GEOFFREY NICHOL
Sentiment: All, MEDX, OVAS, SGMO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2020 | OVAS | Millendo Therapeut ... | NICHOL GEOFFREY | Director | Option Exercise | A | 2.40 | 12,000 | 28,800 | 12,000 | |
| Dec 19 2019 | OVAS | Millendo Therapeut ... | NICHOL GEOFFREY | Director | Option Exercise | A | 6.29 | 24,000 | 150,960 | 24,000 | |
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Payment of Exercise | F | 8.68 | 4,384 | 38,053 | 159,676 | 164.1 K to 159.7 K (-2.67 %) |
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Payment of Exercise | F | 8.68 | 4,697 | 40,770 | 164,060 | 168.8 K to 164.1 K (-2.78 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Option Exercise | A | 9.41 | 75,000 | 705,750 | 75,000 | |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Payment of Exercise | F | 9.69 | 6,889 | 66,754 | 168,757 | 175.6 K to 168.8 K (-3.92 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Grant | A | 0.00 | 37,500 | 0 | 175,646 | 138.1 K to 175.6 K (+27.15 %) |